Investigation of Matrix Metalloproteinases, MMP-2 and MMP-9, in Plasma Reveals a Decrease of MMP-2 in Alzheimer's Disease-Reference-Cited by-同舟云学术

Investigation of Matrix Metalloproteinases, MMP-2 and MMP-9, in Plasma Reveals a Decrease of MMP-2 in Alzheimer's Disease

Published:2011-10-04 Issue:4 Volume:26 Page:779-786
ISSN:1875-8908
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Lim Nastasia K.-H.¹,Villemagne Victor L.¹²,Soon Cynthia P.W.¹,Laughton Katrina M.¹³,Rowe Christopher C.¹²,McLean Catriona A.⁴,Masters Colin L.¹³,Evin Genevieve¹³,Li Qiao-Xin¹³

Affiliation:

1. Department of Pathology, The University of Melbourne, Parkville Vic, Australia

2. Department of Nuclear Medicine, Austin Health, Vic, Australia

3. Mental Health Research Institute, The University of Melbourne, Parkville Vic, Australia

4. Department of Anatomical Pathology, The Alfred Hospital, Commercial Rd, Prahran, Vic., Australia

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heterogeneity of cerebral atrophic rate in mild cognitive impairment and its interactive association with proteins related to microglia activity on longitudinal cognitive changes;Archives of Gerontology and Geriatrics;2024-12

2. The Link Between Matrix Metalloproteinases and Alzheimer’s Disease Pathophysiology;Molecular Neurobiology;2024-06-27

3. Matrix Remodeling Enzymes as Potential Fluid Biomarkers of Neurodegeneration in Alzheimer’s Disease;International Journal of Molecular Sciences;2024-05-24

4. The Genetic Association of MMP-2 Gene Polymorphisms with the Susceptibility to Alzheimer's Disease;Journal of Integrative Neuroscience;2024-03-04

5. A network pharmacology method explores the molecular mechanism of Coptis chinensis for the treatment of Alzheimer’s disease;Medicine;2024-02-02